MedShift Secures $108M in Series C Funding Round to Revolutionize the Aesthetic Industry

We are excited to announce that MedShift has successfully raised $108 million in a recent funding round, marking a significant milestone in our journey to transform the aesthetic healthcare industry.

Founded in 2015 and headquartered in Charlotte, NC, MedShift has emerged as a leading medical technology company, leveraging innovative technology and software as a service (SaaS) solutions to drive growth and efficiency in the healthcare sector.

This latest infusion of capital will allow us to enhance our flagship offerings, including the Velocity Enterprise SaaS, Pulse Connected Product IoT, and the MedShift Store—our comprehensive online marketplace that simplifies access to a wide range of essential medical products and services.

The funding will also support our mission to empower medical device manufacturers and individual providers across various specialties, including Dermatology, Gynecology, Plastic Surgery, and MedSpa.

By expanding our partnerships with over 40 aesthetic manufacturers and distributors and serving more than 2,600 customers, we aim to scale our operations further, streamline supply chains, and drive greater efficiencies in the delivery of healthcare solutions.

MedShift is committed to harnessing the power of modern technology to instigate significant business transformation and enhance sales for our clients across the aesthetic landscape.

As we move forward, we remain dedicated to redefining how the aesthetic industry operates, ensuring that our partners have the tools and resources necessary to succeed in a rapidly evolving market.

This funding round is just the beginning, and we are thrilled about the possibilities that lie ahead!